Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
NCT02493946
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
BIOLOGICAL:
Botulinum toxin type A
DRUG:
Placebo
Sponsor
Ipsen